Canada Pension Plan Investment Board’s Corcept Therapeutics CORT Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.6M	Sell	191,101 -133,800	-41%	-$8.08M	0.01%	583
2026 Q1	$13.1M	Buy	324,901 +200,501	+161%	+$7.5M	0.01%	575
2025 Q4	$4.33M	Sell	124,400 -45,300	-27%	-$3.56M	﹤0.01%	805
2025 Q3	$14.1M	Buy	169,700 +160,100	+1,668%	+$11.6M	0.01%	548
2025 Q2	$705K	Buy	+9,600	New	+$696K	﹤0.01%	998
2025 Q1	–	Sell	-800	Closed	-$40.3K	–	1340
2024 Q4	$40.3K	Buy	+800	New	+$41.9K	﹤0.01%	1331
2021 Q4	–	Sell	-41,000	Closed	-$807K	–	1471
2021 Q3	$807K	Buy	+41,000	New	+$858K	﹤0.01%	1047

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Pension Plan Investment Board's CORT Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Corcept Therapeutics (CORT) stake by 41% in Q2 2026, selling an estimated $8.08M and leaving 191,101 shares worth $16.6M. The position accounts for 0.01% of the portfolio, ranked #583.

Canada Pension Plan Investment Board first reported a position in CORT in Q3 2021 and has held it in 7 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Canada Pension Plan Investment Board held 191,101 shares of Corcept Therapeutics worth $16.6M as of Q2 2026.
Canada Pension Plan Investment Board sold 133,800 Corcept Therapeutics shares in Q2 2026, an estimated $8.08M.
Corcept Therapeutics made up 0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #583 holding.
Canada Pension Plan Investment Board first reported a position in Corcept Therapeutics in Q3 2021 and has held it in 7 quarters since.
422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.